speb/financial-data huggingface dataset:
AGNT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 262880000.00
AGNT cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -274000.00
AGNT cash_flow (quarterly, 2025-06-30) — Deferred Tax: -274000.00
AGNT cash_flow (quarterly, 2025-06-30) — Depreciation: 1587000.00
AGNT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2272000.00
AGNT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2272000.00
AGNT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 156091692.00
AGNT income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.01
AGNT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -2291000.00
AGNT income_statement (quarterly, 2025-06-30) — EBIT: -2376000.00
AGNT income_statement (quarterly, 2025-06-30) — EBITDA: -104000.00
AGNT income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -207000.00
AGNT cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 207000.00
AGNT cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 2064000.00
AGNT cash_flow (quarterly, 2025-06-30) — End Cash Position: 184934000.00
AGNT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -32482000.00
AGNT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 33557000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -24000.00
AGNT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 74076000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Goodwill: 17885000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 23223000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 148464000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 52272000.00
AGNT income_statement (quarterly, 2025-06-30) — Gross Profit: 92654000.00
AGNT cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 534000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 218366000.00
AGNT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -2960000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 51043000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Minority Interest: 0.00
AGNT cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -429000.00
AGNT cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -24887000.00
AGNT income_statement (quarterly, 2025-06-30) — Net Income: -2291000.00
AGNT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -2291000.00
AGNT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -2291000.00
AGNT income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
AGNT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2291000.00
AGNT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2291000.00
AGNT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2291000.00
AGNT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -2291000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Net PPE: 13434000.00
AGNT cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2798000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 195143000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 77557000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 77557000.00
AGNT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -104000.00
AGNT income_statement (quarterly, 2025-06-30) — Normalized Income: -2291000.00
AGNT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 36088000.00
AGNT cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 207000.00
AGNT income_statement (quarterly, 2025-06-30) — Operating Income: -2376000.00
AGNT income_statement (quarterly, 2025-06-30) — Operating Revenue: 1308877000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 156169130.00
AGNT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 13830000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 17014000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -24000.00
AGNT income_statement (quarterly, 2025-06-30) — Other Gand A: 74076000.00
AGNT income_statement (quarterly, 2025-06-30) — Other Income Expense: 553000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 5338000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 22075000.00
AGNT income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 760000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Payables: 11286000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 155862000.00
AGNT income_statement (quarterly, 2025-06-30) — Pretax Income: -1823000.00
AGNT cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 76000.00
AGNT cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 77000.00
AGNT cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -429000.00
AGNT cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2798000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Receivables: 146193000.00
AGNT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1216223000.00
AGNT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2272000.00
AGNT cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -24887000.00
AGNT income_statement (quarterly, 2025-06-30) — Research And Development: 18093000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 90383000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -96723000.00
AGNT income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 2861000.00
AGNT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 76937000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Share Issued: 156169130.00
AGNT income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
AGNT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 38019000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 218366000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 195143000.00
AGNT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AGNT income_statement (quarterly, 2025-06-30) — Tax Provision: 468000.00
AGNT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
AGNT balance_sheet (quarterly, 2025-06-30) — Total Assets: 481246000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 218366000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 218366000.00
AGNT income_statement (quarterly, 2025-06-30) — Total Expenses: 1311253000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 262880000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 136289000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
AGNT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -2376000.00
AGNT income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
AGNT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
AGNT balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 44217271.00
AGNT balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 716549000.00
AGNT balance_sheet (quarterly, 2025-06-30) — Working Capital: 82077000.00
AGNT income_statement (quarterly, 2025-09-30) — +Operating Expense: 82188000.00
AGNT income_statement (quarterly, 2025-09-30) — +Total Revenue: 1316683000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 9781000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 123766000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -40543000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1069515000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -2524000.00
AGNT cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 713000.00
AGNT cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 713000.00
AGNT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 157101785.00
AGNT income_statement (quarterly, 2025-09-30) — Basic EPS: 0.02
AGNT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 184934000.00
AGNT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2595000.00
AGNT cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -260000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 112761000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 112761000.00
AGNT cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -7705000.00
AGNT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -24007000.00
AGNT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3285000.00
AGNT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 28891000.00
AGNT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1506000.00
AGNT cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -22085000.00
AGNT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -16395000.00
AGNT cash_flow (quarterly, 2025-09-30) — Change In Payable: -1506000.00
AGNT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -23591000.00
AGNT cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 829000.00
AGNT cash_flow (quarterly, 2025-09-30) — Change In Receivables: 22174000.00
AGNT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -16983000.00
AGNT cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 22174000.00
AGNT cash_flow (quarterly, 2025-09-30) — Changes In Cash: 1599000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
AGNT cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -7705000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 235265000.00
AGNT cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -16358000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 276000.00
AGNT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1230479000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 123074000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Current Assets: 323148000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 73465000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 73465000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 223478000.00
AGNT cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 1122000.00
AGNT cash_flow (quarterly, 2025-09-30) — Deferred Tax: 1122000.00
AGNT cash_flow (quarterly, 2025-09-30) — Depreciation: 1711000.00
AGNT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2424000.00
AGNT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2424000.00
AGNT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 160767662.00
AGNT income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.02
AGNT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 3497000.00
AGNT income_statement (quarterly, 2025-09-30) — EBIT: 4016000.00
AGNT income_statement (quarterly, 2025-09-30) — EBITDA: 6440000.00
AGNT income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -195000.00
AGNT cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 195000.00
AGNT cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -152000.00
AGNT cash_flow (quarterly, 2025-09-30) — End Cash Position: 186381000.00
AGNT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -24007000.00
AGNT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 26296000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -414000.00
AGNT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 62341000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Goodwill: 17647000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 22532000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 126290000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 54601000.00
AGNT income_statement (quarterly, 2025-09-30) — Gross Profit: 86204000.00
AGNT cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1532000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 235265000.00
AGNT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3285000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 54325000.00
AGNT cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -690000.00
AGNT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -16358000.00
AGNT income_statement (quarterly, 2025-09-30) — Net Income: 3497000.00
AGNT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 3497000.00
AGNT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 3497000.00
AGNT income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
AGNT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 3497000.00
AGNT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 3497000.00
AGNT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 3497000.00
AGNT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 3497000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Net PPE: 14058000.00
AGNT cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2335000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 212733000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 76435000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 76435000.00
AGNT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 6440000.00
AGNT income_statement (quarterly, 2025-09-30) — Normalized Income: 3497000.00
AGNT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 28891000.00
AGNT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 195000.00
AGNT income_statement (quarterly, 2025-09-30) — Operating Income: 4016000.00
AGNT income_statement (quarterly, 2025-09-30) — Operating Revenue: 1316683000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 158836724.00
AGNT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 13001000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 17158000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -414000.00
AGNT income_statement (quarterly, 2025-09-30) — Other Gand A: 62341000.00
AGNT income_statement (quarterly, 2025-09-30) — Other Income Expense: 413000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 4885000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 22570000.00
AGNT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 608000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Payables: 9781000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 132855000.00
AGNT income_statement (quarterly, 2025-09-30) — Pretax Income: 4429000.00
AGNT cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 56000.00
AGNT cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 253000.00
AGNT cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -690000.00
AGNT cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2335000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Receivables: 123766000.00
AGNT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1230479000.00
AGNT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2424000.00
AGNT cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -16358000.00
AGNT income_statement (quarterly, 2025-09-30) — Research And Development: 17312000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 73620000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -100931000.00
AGNT income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 2535000.00
AGNT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 64876000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Share Issued: 204643680.00
AGNT income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
AGNT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 38383000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 235265000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 212733000.00
AGNT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AGNT income_statement (quarterly, 2025-09-30) — Tax Provision: 932000.00
AGNT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
AGNT balance_sheet (quarterly, 2025-09-30) — Total Assets: 458743000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 235265000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 235265000.00
AGNT income_statement (quarterly, 2025-09-30) — Total Expenses: 1312667000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 223478000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 135595000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
AGNT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 4016000.00
AGNT income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
AGNT income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
AGNT balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 45806956.00
AGNT balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 732907000.00
AGNT balance_sheet (quarterly, 2025-09-30) — Working Capital: 99670000.00
AGNT income_statement (annual, 2025-12-31) — +Operating Expense: 355044000.00
AGNT income_statement (quarterly, 2025-12-31) — +Operating Expense: 91315000.00
AGNT income_statement (annual, 2025-12-31) — +Total Revenue: 4772311000.00
AGNT income_statement (quarterly, 2025-12-31) — +Total Revenue: 1191845000.00
AGNT balance_sheet (annual, 2025-12-31) — Accounts Payable: 14613000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 14613000.00
AGNT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 108838000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 108838000.00
AGNT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -42184000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -42184000.00
AGNT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1105434000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1105434000.00
AGNT balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2690000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2690000.00
AGNT cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 2692000.00
AGNT cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 678000.00
AGNT cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 2692000.00
AGNT cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 678000.00
AGNT cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
AGNT income_statement (annual, 2025-12-31) — Basic Average Shares: 156879412.00
AGNT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 159530894.00
AGNT income_statement (annual, 2025-12-31) — Basic EPS: -0.14
AGNT income_statement (quarterly, 2025-12-31) — Basic EPS: -0.08
AGNT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 168588000.00
AGNT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 186381000.00
AGNT cash_flow (annual, 2025-12-31) — Capital Expenditure: -10226000.00
AGNT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -2097000.00
AGNT cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -657000.00
AGNT cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -214000.00
AGNT balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
AGNT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 124245000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 124245000.00
AGNT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 124245000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 124245000.00
AGNT cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -30773000.00
AGNT cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -7795000.00
AGNT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -86538000.00
AGNT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -17765000.00
AGNT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -23472000.00
AGNT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2980000.00
AGNT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 118611000.00
AGNT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 13794000.00
AGNT cash_flow (annual, 2025-12-31) — Change In Account Payable: 4135000.00
AGNT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 4833000.00
AGNT cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 21810000.00
AGNT cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -14799000.00
AGNT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -12834000.00
AGNT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -13743000.00
AGNT cash_flow (annual, 2025-12-31) — Change In Payable: 4135000.00
AGNT cash_flow (quarterly, 2025-12-31) — Change In Payable: 4833000.00
AGNT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 25945000.00
AGNT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -9966000.00
AGNT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -2875000.00
AGNT cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1566000.00
AGNT cash_flow (annual, 2025-12-31) — Change In Receivables: -21098000.00
AGNT cash_flow (quarterly, 2025-12-31) — Change In Receivables: 14761000.00
AGNT cash_flow (annual, 2025-12-31) — Change In Working Capital: -10862000.00
AGNT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -10514000.00
AGNT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -21098000.00
AGNT cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 14761000.00
AGNT cash_flow (annual, 2025-12-31) — Changes In Cash: 8601000.00
AGNT cash_flow (quarterly, 2025-12-31) — Changes In Cash: -6951000.00
AGNT balance_sheet (annual, 2025-12-31) — Common Stock: 2000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000.00
AGNT cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -30773000.00
AGNT cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -7795000.00
AGNT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 242779000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 242779000.00
AGNT cash_flow (annual, 2025-12-31) — Common Stock Payments: -56199000.00
AGNT cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -9972000.00
AGNT balance_sheet (annual, 2025-12-31) — Construction In Progress: 443000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 443000.00
AGNT income_statement (annual, 2025-12-31) — Cost Of Revenue: 4438733000.00
AGNT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1113260000.00
AGNT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 23308000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 23308000.00
AGNT balance_sheet (annual, 2025-12-31) — Current Assets: 304868000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Current Assets: 304868000.00
AGNT balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 57204000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 57204000.00
AGNT balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 57204000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 57204000.00
AGNT balance_sheet (annual, 2025-12-31) — Current Liabilities: 199701000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 199701000.00
AGNT cash_flow (annual, 2025-12-31) — Deferred Income Tax: -1736000.00
AGNT cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -1075000.00
AGNT cash_flow (annual, 2025-12-31) — Deferred Tax: -1736000.00
AGNT cash_flow (quarterly, 2025-12-31) — Deferred Tax: -1075000.00
AGNT cash_flow (annual, 2025-12-31) — Depreciation: 6870000.00
AGNT cash_flow (quarterly, 2025-12-31) — Depreciation: 1627000.00
AGNT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 9562000.00
AGNT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2305000.00
AGNT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 9562000.00
AGNT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2305000.00
AGNT income_statement (annual, 2025-12-31) — Diluted Average Shares: 156879412.00
AGNT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 159530894.00
AGNT income_statement (annual, 2025-12-31) — Diluted EPS: -0.14
AGNT income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.08
AGNT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -22714000.00
AGNT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -12896000.00
AGNT income_statement (annual, 2025-12-31) — EBIT: -21466000.00
AGNT income_statement (quarterly, 2025-12-31) — EBIT: -12730000.00
AGNT income_statement (annual, 2025-12-31) — EBITDA: -11904000.00
AGNT income_statement (quarterly, 2025-12-31) — EBITDA: -10425000.00
AGNT income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -281000.00
AGNT income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 41000.00
AGNT cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 281000.00
AGNT cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -41000.00
AGNT cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 4274000.00
AGNT cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 2033000.00
AGNT cash_flow (annual, 2025-12-31) — End Cash Position: 181463000.00
AGNT cash_flow (quarterly, 2025-12-31) — End Cash Position: 181463000.00
AGNT cash_flow (annual, 2025-12-31) — Financing Cash Flow: -86538000.00
AGNT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -17765000.00
AGNT cash_flow (annual, 2025-12-31) — Free Cash Flow: 108385000.00
AGNT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 11697000.00
AGNT cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
AGNT balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1844000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1844000.00
AGNT income_statement (annual, 2025-12-31) — General And Administrative Expense: 274871000.00
AGNT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 71583000.00
AGNT balance_sheet (annual, 2025-12-31) — Goodwill: 17872000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Goodwill: 17872000.00
AGNT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 22293000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 22293000.00
AGNT balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 111528000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 111528000.00
AGNT balance_sheet (annual, 2025-12-31) — Gross PPE: 56498000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 56498000.00
AGNT income_statement (annual, 2025-12-31) — Gross Profit: 333578000.00
AGNT income_statement (quarterly, 2025-12-31) — Gross Profit: 78585000.00
AGNT cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 4597000.00
AGNT cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1051000.00
AGNT balance_sheet (annual, 2025-12-31) — Invested Capital: 242779000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 242779000.00
AGNT cash_flow (annual, 2025-12-31) — Investing Cash Flow: -23472000.00
AGNT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -2980000.00
AGNT balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 56055000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 56055000.00
AGNT cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -13246000.00
AGNT cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -883000.00
AGNT cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -56199000.00
AGNT cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -9972000.00
AGNT income_statement (annual, 2025-12-31) — Net Income: -22714000.00
AGNT income_statement (quarterly, 2025-12-31) — Net Income: -12896000.00
AGNT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -22714000.00
AGNT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -12896000.00
AGNT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -22714000.00
AGNT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -12896000.00
AGNT income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
AGNT income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
AGNT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -22714000.00
AGNT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -12896000.00
AGNT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -22714000.00
AGNT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -12896000.00
AGNT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -22714000.00
AGNT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -12896000.00
AGNT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -22714000.00
AGNT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -12896000.00
AGNT balance_sheet (annual, 2025-12-31) — Net PPE: 14314000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Net PPE: 14314000.00
AGNT cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -9569000.00
AGNT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1883000.00
AGNT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 220486000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 220486000.00
AGNT balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 77510000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 77510000.00
AGNT balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 77510000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 77510000.00
AGNT income_statement (annual, 2025-12-31) — Normalized EBITDA: -11904000.00
AGNT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -10425000.00
AGNT income_statement (annual, 2025-12-31) — Normalized Income: -22714000.00
AGNT income_statement (quarterly, 2025-12-31) — Normalized Income: -12896000.00
AGNT cash_flow (annual, 2025-12-31) — Operating Cash Flow: 118611000.00
AGNT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 13794000.00
AGNT cash_flow (annual, 2025-12-31) — Operating Gains Losses: 281000.00
AGNT cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -41000.00
AGNT income_statement (annual, 2025-12-31) — Operating Income: -21466000.00
AGNT income_statement (quarterly, 2025-12-31) — Operating Income: -12730000.00
AGNT income_statement (annual, 2025-12-31) — Operating Revenue: 4772311000.00
AGNT income_statement (quarterly, 2025-12-31) — Operating Revenue: 1191845000.00
AGNT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 161049979.00
AGNT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 161049979.00
AGNT balance_sheet (annual, 2025-12-31) — Other Current Assets: 3232000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 3232000.00
AGNT balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 19676000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 19676000.00
AGNT balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 1844000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 1844000.00
AGNT income_statement (annual, 2025-12-31) — Other Gand A: 274871000.00
AGNT income_statement (quarterly, 2025-12-31) — Other Gand A: 71583000.00
AGNT income_statement (annual, 2025-12-31) — Other Income Expense: 1232000.00
AGNT income_statement (quarterly, 2025-12-31) — Other Income Expense: -757000.00
AGNT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 4421000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 4421000.00
AGNT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 23495000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 23495000.00
AGNT income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1513000.00
AGNT income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -798000.00
AGNT balance_sheet (annual, 2025-12-31) — Other Payable: 81109000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Other Payable: 81109000.00
AGNT balance_sheet (annual, 2025-12-31) — Payables: 99513000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Payables: 99513000.00
AGNT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 122821000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 122821000.00
AGNT balance_sheet (annual, 2025-12-31) — Prepaid Assets: 11335000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 11335000.00
AGNT income_statement (annual, 2025-12-31) — Pretax Income: -20234000.00
AGNT income_statement (quarterly, 2025-12-31) — Pretax Income: -13487000.00
AGNT cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 434000.00
AGNT cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 2000.00
AGNT cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 1101000.00
AGNT cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 166000.00
AGNT cash_flow (annual, 2025-12-31) — Purchase Of Business: -13246000.00
AGNT cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -883000.00
AGNT cash_flow (annual, 2025-12-31) — Purchase Of PPE: -9569000.00
AGNT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1883000.00
AGNT balance_sheet (annual, 2025-12-31) — Receivables: 108838000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Receivables: 108838000.00
AGNT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 4438733000.00
AGNT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1113260000.00
AGNT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 9562000.00
AGNT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2305000.00
AGNT cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -56199000.00
AGNT cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -9972000.00
AGNT income_statement (annual, 2025-12-31) — Research And Development: 69618000.00
AGNT income_statement (quarterly, 2025-12-31) — Research And Development: 17408000.00
AGNT balance_sheet (annual, 2025-12-31) — Restricted Cash: 57218000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 57218000.00
AGNT balance_sheet (annual, 2025-12-31) — Retained Earnings: -121622000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -121622000.00
AGNT cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
AGNT income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 10555000.00
AGNT income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 2324000.00
AGNT income_statement (annual, 2025-12-31) — Selling General And Administration: 285426000.00
AGNT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 73907000.00
AGNT balance_sheet (annual, 2025-12-31) — Share Issued: 207785762.00
AGNT balance_sheet (quarterly, 2025-12-31) — Share Issued: 207785762.00
AGNT income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
AGNT income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
AGNT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 142979000.00
AGNT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 35849000.00
AGNT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 242779000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 242779000.00
AGNT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 220486000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 220486000.00
AGNT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AGNT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AGNT income_statement (annual, 2025-12-31) — Tax Provision: 2480000.00
AGNT income_statement (quarterly, 2025-12-31) — Tax Provision: -591000.00
AGNT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
AGNT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.04
AGNT balance_sheet (annual, 2025-12-31) — Total Assets: 442480000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Total Assets: 442480000.00
AGNT balance_sheet (annual, 2025-12-31) — Total Capitalization: 242779000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 242779000.00
AGNT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 242779000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 242779000.00
AGNT income_statement (annual, 2025-12-31) — Total Expenses: 4793777000.00
AGNT income_statement (quarterly, 2025-12-31) — Total Expenses: 1204575000.00
AGNT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 199701000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 199701000.00
AGNT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 137612000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 137612000.00
AGNT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
AGNT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
AGNT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -21466000.00
AGNT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -12730000.00
AGNT balance_sheet (annual, 2025-12-31) — Total Tax Payable: 3791000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 3791000.00
AGNT income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
AGNT income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
AGNT income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AGNT income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AGNT balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 46735783.00
AGNT balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 46735783.00
AGNT balance_sheet (annual, 2025-12-31) — Treasury Stock: 742879000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 742879000.00
AGNT balance_sheet (annual, 2025-12-31) — Working Capital: 105167000.00
AGNT balance_sheet (quarterly, 2025-12-31) — Working Capital: 105167000.00
AGNT income_statement (annual, 2025-12-31) — Write Off: 0.00
AGNT income_statement (quarterly, 2026-03-31) — +Operating Expense: 84135000.00
AGNT income_statement (quarterly, 2026-03-31) — +Total Revenue: 1005541000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 13529000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 123176000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -43846000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1133497000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -2539000.00
AGNT cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 643000.00
AGNT cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 643000.00
AGNT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 162017200.00
AGNT income_statement (quarterly, 2026-03-31) — Basic EPS: -0.03
AGNT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 181463000.00
AGNT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2149000.00
AGNT cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: 365000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 122149000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 122149000.00
AGNT cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -7970000.00
AGNT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -7949000.00
AGNT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -2089000.00
AGNT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 20571000.00
AGNT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -1083000.00
AGNT cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 1512000.00
AGNT cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 10103000.00
AGNT cash_flow (quarterly, 2026-03-31) — Change In Payable: -1083000.00
AGNT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 429000.00
AGNT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -575000.00
AGNT cash_flow (quarterly, 2026-03-31) — Change In Receivables: -14023000.00
AGNT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -4066000.00
AGNT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -14023000.00
AGNT cash_flow (quarterly, 2026-03-31) — Changes In Cash: 10533000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Common Stock: 2000.00
AGNT cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -7970000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 255900000.00
AGNT cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
AGNT balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1904000.00
AGNT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 930194000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 110753000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Current Assets: 328677000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 68224000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 68224000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 211266000.00
AGNT cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -1675000.00
AGNT cash_flow (quarterly, 2026-03-31) — Deferred Tax: -1675000.00
AGNT cash_flow (quarterly, 2026-03-31) — Depreciation: 1679000.00
AGNT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 2322000.00
AGNT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 2322000.00
AGNT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 162017200.00
AGNT income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.03
AGNT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -5098000.00
AGNT income_statement (quarterly, 2026-03-31) — EBIT: -8788000.00
AGNT income_statement (quarterly, 2026-03-31) — EBITDA: -6466000.00
AGNT income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -130000.00
AGNT cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 165000.00
AGNT cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1637000.00
AGNT cash_flow (quarterly, 2026-03-31) — End Cash Position: 190359000.00
AGNT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -7949000.00
AGNT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 18422000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -30000.00
AGNT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 64213000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Goodwill: 17635000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 21048000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 125715000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 58995000.00
AGNT income_statement (quarterly, 2026-03-31) — Gross Profit: 75347000.00
AGNT cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 1397000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 255900000.00
AGNT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -2089000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 57091000.00
AGNT cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 60000.00
AGNT cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
AGNT income_statement (quarterly, 2026-03-31) — Net Income: -5098000.00
AGNT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -5098000.00
AGNT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -5098000.00
AGNT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -5098000.00
AGNT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -5098000.00
AGNT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -5098000.00
AGNT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -5098000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Net PPE: 15149000.00
AGNT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -2514000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 234852000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 79186000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 79186000.00
AGNT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -6466000.00
AGNT income_statement (quarterly, 2026-03-31) — Normalized Income: -5098000.00
AGNT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 20571000.00
AGNT cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 165000.00
AGNT income_statement (quarterly, 2026-03-31) — Operating Income: -8788000.00
AGNT income_statement (quarterly, 2026-03-31) — Operating Revenue: 1005541000.00
AGNT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 164323924.00